AI Drug Reverses Aging Markers in Trial; OpenAI Warns on Pace
Insilico's AI drug cuts biological age in trial, while OpenAI reports research agents and flags alignment risks.
Sources:
AI-designed drug appears to turn back the body's biological clock in early trial
OpenAI reports AI "research interns" and warns about its own pace at the same time
Qwen-Drive 1.0 tells you why it brakes, just don't expect the explanation to match the maneuver
Cathay Pacific and Google partner on AI contrail avoidance for ultra-long-haul flights
AI coding agents shift corporate tech spending: Companies build software internally over buying
📰 Read the full edition on the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.